GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Institutional Ownership

OncoTherapy Science (TSE:4564) Institutional Ownership : 0.34% (As of Apr. 30, 2025)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OncoTherapy Science's institutional ownership is 0.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OncoTherapy Science's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OncoTherapy Science's Float Percentage Of Total Shares Outstanding is 0.00%.


OncoTherapy Science Institutional Ownership Historical Data

The historical data trend for OncoTherapy Science's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Institutional Ownership Chart

OncoTherapy Science Historical Data

The historical data trend for OncoTherapy Science can be seen below:

2023-04-30 2023-05-31 2023-07-31 2023-08-31 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.32 0.32 0.31 0.30 0.42 0.42 0.42 0.39 0.36 0.34

OncoTherapy Science Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


OncoTherapy Science Business Description

Traded in Other Exchanges
N/A
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines